Stanford Students in Biodesign and Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Stanford Students in Biodesign and Biopharma's estimated annual revenue is currently $4.3M per year.
- Stanford Students in Biodesign and Biopharma's estimated revenue per employee is $155,000
Employee Data
- Stanford Students in Biodesign and Biopharma has 28 Employees.
- Stanford Students in Biodesign and Biopharma grew their employee count by 22% last year.
Stanford Students in Biodesign and Biopharma's People
Name | Title | Email/Phone |
---|
Stanford Students in Biodesign and Biopharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Stanford Students in Biodesign and Biopharma?
Stanford Students in Biodesign and Biopharma is the largest student group at Stanford for those interested in building products and technology for healthcare and biomedicine. Founded in 2001, we aim to cultivate and support an environment of healthcare innovation for students in engineering, design, and pre-health disciplines. We are supported by Stanford Byers Center for Biodesign and the Stanford School of Medicine, who share our goal of encouraging interdisciplinary collaboration when tackling problems in healthcare.
keywords:N/AN/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.5M | 29 | -29% | N/A |
#2 | $5M | 30 | 7% | N/A |
#3 | N/A | 31 | 0% | N/A |
#4 | $2.6M | 32 | -18% | N/A |
#5 | $3.5M | 33 | -21% | N/A |